Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane and Cetuximab in Recurrent/Metastatic Head and Neck Cancer
NCT00319839Phase 2Terminated
- Sponsor
- University of California, Irvine
- Start
- Mar 2006
- Primary completion
- May 2009
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in head and neck squamous cell carcinoma (HNSCC), sponsored by University of California, Irvine. Started Mar 2006; status: terminated.
02
Drugs
nab-paclitaxel
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00319839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319839.